References
- Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 2002; 94:1546-54.
- Gajdos C, Tartter PI, Bleiweiss IJ, Hermann G, de Csepel J, Estabrook A, et al. Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics. Ann Surg 2002; 235: 246-51.
- de Roos MA, van der Vegt B, de Vries J, Wesseling J, de Bock GH. Pathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breast. Ann Surg Oncol 2007; 14:2097-104.
- Holland R, Hendriks JH, Vebeek AL, Mruvanac M, Schuurmans Stekhoven JH. Extent, distribution, and mammographic/histological correlation of breast ductal carcinoma in situ. Lancet 1990; 335:519-22.
- Henrot P, Leroux A, Barlier C, Genin P. Breast microcalcifications: The lesions in anatomical pathology. Diagn Interv Imaging 2014; 95: 141-52.
- Faverly DR, Burgers L, Bult P, Holland R: Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol 1994; 11:193-8.
- Mai KT, Yazdi HM, Burns BF, Perkins DG. Pattern of distribution of intraductal and infiltrating ductal carcinoma: a three-dimensional study using serial coronal giant sections of the breast. Hum Pathol 2000; 31:464-74.
- de Ross MAJ, Pijnappel RM, Post WJ, de Vries J, Baas PC, Groote LD. Correlation between imaging nad pathology in ductal carcinoma in situ of the breast. World J Surg Oncol 2004; 2: 4.
- Lester SC, Bose S, Chen YY, Connolly JL, de Baca ME, Fitzgibbons PL, et al. Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast. Arch Pathol Lab Med 2009; 133: 15-25.
- Schwartz GF, Lagios MD, Carter D, Connolly J, Ellis IO, Eusebi V, et al. Consensus conference on the classification of ductal carcinoma in situ. Cancer 1997; 80: 1798-802.
- Tabar L, Tot T, Dean PB. Breast Cancer: The art and science of early detection with mammography. Stuttgart, New York: Thieme; 2005.
- Silverstein MJ, Lagios MD. Treatment selection for patients with ductal carcinoma in situ (DCIS) of the breast using the University of Southern California/ Van Nuys (USC/VNPI) Prognostic Index. Breast J 2015; 21:127-32.
- Dinkel HP, Gassel AM, Tschammler A. Is the appearance of microcalcifications on mammography useful in predicting histological grade of malignancy in ductal cancer in situ? Br J Radiol 2000; 73: 938-44.
- Slanetz PJ, Giardino AA, Oyama T, Koerner FC, Halpern EF, Moore RH, et al. Mammographic appearance of ductal carcinoma in situ does not reliably predict histologic subtype. Breast J 2001; 7: 417-21.
- Holland R, Hendriks JH. Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin Diagn Pathol 1994; 11: 181-92.
- Evans A, Clements K, Maxwell A, Bishop H, Hanby A, Lawrence G, et al. Sloane Projest Steering Group: Lesion size is major determinant of the mammograhic features of ductal carcinoma in situ: findings from the Sloane Project. Clin Radiol 2010; 65: 181-4.
- Barreau B, de Mascarel I, Feuga C, MacGrogan G, Dilhuydy MH, Picot V, et al. Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic-pathologic correlations. Eur J Radiol 2005; 54: 55-61.
- Evans A, Pinder S, Wilson R, Sibbering M, et al. Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings. AJR Am J Roentgenol 1994; 162: 1307-11.
- Stomper PC, Connolly JL. Ductal carcinoma in situ of the breast: correlation between mammographic calcification and tumor subtype. AJR Am J Roentgenol 1992; 159: 483-5.
- Tang X, Yamashita T, Hara M, Kumaki N, Tokuda Y, Masuda S. Histopathological characteristics of breast ductal carcinoma in situ and association with imaging findings. Breast Cancer 2015; Feb 3 [DOI10.1007/s12282-015-0592-0 Epub ahead of print].
- Cho KR, Seo BK, Kim CH, Whang KW, Kim YH, Woo OH, et al. Non-calcified ductal carcinoma in situ: ultrasound and mammographic findings correlated with histological findings. Yonsei Med J 2008; 49: 103-10.
- Schulz S, Sinn P, Golatta M, Rauch G, Junkermann H, Schuetz F, et al. Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy. Breast 2013; 22: 537-42.
- Park HS, Park S, Cho J, Park JM, Kim SI, Park BW. Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy. J Surg Oncol 2013; 107: 388-92.
- Szynglarewicz B, Kasprzak P, Halon A, Matkowski R. Preoperatively diagnosed ductal cancers in situ of the breast presenting as even small masses are of high risk for the invasive foci in postoperative specimen. World J Surg Oncol 2015; 13: 218.
- Bae S, Yoon JH, Moon HJ, Kim MJ, Kim EK. Breast microcalcifications: diagnostic outcomes according to image-guided biopsy method. Korean J Radiol 2015; 16: 996-1005.
- Rauch GM, Kuerer HM, Scoggins ME, Fox PS, Benveniste AP, Park YM, et al. Clinicopathologic, mammographic, and sonographic features in 1,187 patients with pure ductal carcinoma in situ of the breast by estrogen receptor status. Breast Cancer Res Treat 2013; 139: 639-47.
- Mun HS, Shin HJ, Kim HH, Cha JH, Kim H. Screening-detected calcified and non-calcified ductal carcinoma in situ: differences in the imaging and histopathological features. Clin Radiol 2013; 68: e27-35.
- Kim MY, Kim HS, Choi N, Yang JH, Yoo YB, Park KS. Screening mammography-detected ductal carcinoma in situ: mammographic features based on breast cancer subtypes. Clin Imaging 2015; 39: 983-6.